Cargando…

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

BACKGROUND: Different molecular subtypes of breast cancer have been identified based on gene expression profiling. Treatment suggestions based on an approximation of these subtypes by immunohistochemical criteria have been published by the St Gallen international expert consensus panel. Ductal carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenjing, Jirström, Karin, Amini, Rose-Marie, Fjällskog, Marie-Louise, Sollie, Thomas, Lindman, Henrik, Sørlie, Therese, Blomqvist, Carl, Wärnberg, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228470/ https://www.ncbi.nlm.nih.gov/pubmed/24171825 http://dx.doi.org/10.1186/1471-2407-13-512

Ejemplares similares

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2010)

Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort
por: Zhou, Wenjing, et al.
Publicado: (2017)

Breast Cancer with Neoductgenesis: Histopathological Criteria and Its Correlation with Mammographic and Tumour Features
por: Zhou, Wenjing, et al.
Publicado: (2014)

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
por: Bergholtz, Helga, et al.
Publicado: (2020)

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
por: Ahlin, Cecilia, et al.
Publicado: (2017)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
por: Hagerling, Catharina, et al.
Publicado: (2020)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
por: Agustsson, Arnar S., et al.
Publicado: (2020)

Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
por: Yang, Libo, et al.
Publicado: (2022)

Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment
por: Liu, Yufei, et al.
Publicado: (2020)

Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study
por: Rask, Gunilla, et al.
Publicado: (2022)

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden
por: Lindman, Henrik, et al.
Publicado: (2022)

Ghrelin expression is associated with a favorable outcome in male breast cancer
por: Grönberg, Malin, et al.
Publicado: (2018)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
por: Behbod, Fariba, et al.
Publicado: (2009)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
por: Karakatsanis, Andreas, et al.
Publicado: (2023)

Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
por: Wärnberg, Fredrik, et al.
Publicado: (2006)

Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor
por: Hwang, Ki‐Tae, et al.
Publicado: (2021)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
por: Bergholtz, Helga, et al.
Publicado: (2022)

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ
por: Jiang, YunQing, et al.
Publicado: (2014)

Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact
por: Schandiz, Hossein, et al.
Publicado: (2023)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Women Treated for Breast Cancer Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain, and Future Reflections
por: Hellerstedt-Börjesson, Susanne, et al.
Publicado: (2016)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy
por: Clark, Andrea J., et al.
Publicado: (2016)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
por: Aaltonen, K, et al.
Publicado: (2006)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
por: Jirström, K, et al.
Publicado: (2003)

The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer
por: Strand, Carina, et al.
Publicado: (2013)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5tabmt06tkqrav2ji4sbsuq9i9